The invariant chain (Ii), a nonpolymorphic glycoprotein that associates with the immunoregulatory Ia proteins encoded by the major histocompatibility complex, has a proteoglycan form (Ii-CS) that bears a chondroitin sulfate glycosaminoglycan. In this proteoglycan form, Ii may remain associated with Ia at the cell surface. Inhibitors that prevent
Ili-CS. The mutant protein had apparently normal transport through the Golgi compartment and associated stably with Ia molecules. Thus, this mutation directly identifies the site of glycosaminoglycan addition and shows that it can be eliminated without adversely affecting the overall biosynthesis of Ii.
The class II (Ia) gene products of the major histocompatibility complex are molecules whose structural variation influences the ability of helper T cells to recognize processed exogenous antigen (1, 2) . These immunoregulatory molecules are composed of a and f chains encoded by the major histocompatibility complex. In addition, the a and B chains are intracellularly associated with a nonpolymorphic glycoprotein called invariant chain (Ii) (3), which is encoded by a single gene (4, 5) . The most abundant form of Ii is a Mr 31,000 protein, though several other polypeptide forms of the Ii protein are found because of production of two differentially spliced mRNAs (6, 7) and because translation can be initiated at two different start codons (6, 8) .
The association between the Ia a,8 heterodimer and the Mr 31,000 Ii begins in the endoplasmic reticulum, where an excess of Ii is made. All three chains in the a/3li complex undergo coordinate posttranslational processing events. In addition to N-and O-linked oligosaccharides, some Ii chains receive the unusual addition of a chondroitin sulfate glycosaminoglycan (GAG) during Golgi processing (9, 10) , increasing their size to M, 45 ,000-70,000. Mr 31,000 Ii dissociates from the Ia heterodimer sometime between the trans-Golgi compartment and insertion of Ia into the plasma membrane, but some surface Ia continues to be associated with the GAG-bearing form of Ii (Ii-CS) (11) . The specific association of Ii and Ia during biosynthesis (12, 13) led to the suggestion that Ii has a role in intracellular transport of Ia. However, Ia can be transported to the cell surface in Ii-negative (Ii -) transfectants carrying only Ia cDNA clones (14, 15) . Thus, the function of Ii has not been determined. Treatment of antigen-presenting cells with inhibitors of GAG addition (xylosides) interferes with their ability to present antigen to T cells, suggesting that li-CS may have a specialized role in helper-T-cell recognition (16, 17) . In order to examine the role of Ii-CS more specifically, and to understand the biochemistry of Ii biosynthesis and GAG addition, we made a site-specific mutation in the predicted site of GAG addition in Ii. Site-Directed Mutagenesis. The mismatched-primerextension method (21) of in vitro mutagenesis was performed on a 1.3-kilobase full-length cDNA insert from pcEXV-mIi3 (A. Sant, R. Germain, and J.M., unpublished work) subcloned into phage vector M13mp9 (22) . After second-strand synthesis and ligation, nuclease S1 digestion of unprimed template DNA, and transfection into Escherichia coli JM101, plaques were screened by hybridization to the mutagenic oligonucleotide. Mutated phage were replated and plaque-purified. The DNA sequence of the entire Ii mutant coding region was determined (23) . The insert was transferred into the cDNA expression vector pcEXV-gpt (F. Ronchese and R. Germain, unpublished), a modification of pcEXV-1 that contains the E. coli xanthine (guanine) phosphoribosyltransferase gene.
DNA-Mediated Gene Transfer. Transient transfection into COS-7 cells (106 cells per 100-mm dish) was performed with plasmid DNA (2 pLg/ml) and DEAE-dextran (500 ,ug/ml), followed after 3-4 hr by 20% glycerol shock (24) . Transiently transfected cells were harvested after 48-60 hr and either solubilized directly for immunoblotting or radiolabeled and solubilized for immunoprecipitation. In previous studies (14, 25) , flow microfluorimetry had shown that typically 10-20% of COS-7 cells expressed the surface products of transfected genes.
Abbreviations: GAG, glycosaminoglycan; Ii, invariant chain; Ii-CS, invariant chain bearing chondroitin sulfate; NEPHGE, nonequilibrium pH gradient electrophoresis.
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Stable transfection of BALB/c mouse 3T3 cells was carried out using calcium phosphate-precipitated DNA (26) . A BALB/c 3T3 cell transfectant, BADH3.1, originally called BdH3.1 (14) , that expressed cell surface I-Ad a and f chains but not endogenous Ii was transfected by overnight incubation with precipitated purified plasmid DNA (10Lg/ml) containing the wild-type or the mutated Ii cDNA clones inserted into pcEXV-gpt. After incubation for 24 hr in fresh medium, the cells were selected in medium containing mycophenolic acid (6 ug/ml), hypoxanthine (15 ,tg/ml), and xanthine (250 gg/ml). Clones (9) . Lysates of radiolabeled or unlabeled cells were prepared and treated as previously noted (9) . Protein blotting from 10% acrylamide gels was performed (27) , and Ii protein was identified on blots by means of the monoclonal anti-Ii reagent In-l. Two-dimensional electrophoretic analysis (28) was performed using a 3:1:1 ratio of pH 5-8, pH 8-9.5, and pH 3-10 Ampholines (LKB) for nonequilibrium pH-gradient electrophoresis (NEPHGE). First-dimension NEPHGE gels were run at 400 V for 4 hr, and NaDodSO4/polyacrylamide gels were used for the second dimension.
RESULTS
All chondroitin sulfate GAGs thus far described are attached to protein by an 0-glycosidic linkage between xylose and serine (29) (30) (31) . Analysis of synthetic peptides containing putative GAG-acceptor sites established that xylosyltransferase preferentially recognizes Ser-Gly sequences (32) . Attachment of GAG in several proteins has been localized to Ser-Gly sites by direct evidence (33, 34) . Examination of the murine Ii DNA sequence (35, 36) encoding the predominant 215 amino acid (Mr 31,000) form of Ii showed two Ser-Gly sites at Ser-132 and Ser-201. Since the Ii protein has reverse polarity in cell membranes (37) , both sites are in the presumed extracellular domain of the molecule. The Ser-132 site is close to the sites for attachment of N-linked oligosaccharides (Asn-113 and Asn-119) and is not conserved in the human Ii cDNA sequence (38) . Because the human Ii-CS has molecular properties comparable to those of murine Ii-CS (39) , lack of conservation made the Ser-132 site a less attractive acceptor candidate. We concluded that Ser-201 was the most likely candidate for GAG addition.
To directly test whether Ser-201 was the initiation site for the GAG in the murine Ii chain, a single conservative mutation (serine to alanine) was introduced into the Ii cDNA clone pcEXV-mli3 (Fig. 1 Proc. Natl. Acad. Sci. USA 85 (1988) 
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A. forms of the Ii protein and, hence, that both forms move through the Golgi and undergo similar processing except for GAG addition.
To examine the ability of the mutant Ii to interact with Ia molecules, stable transfectants of BALB/c 3T3 cells expressing Ia a and f3 chains but not Ii (BADH3.1) (14) were supertransfected with the wild-type and mutant constructs. a,3 a ,1 +wtI1 +1i-010201
As in the COS-7 system, precipitation with the monoclonal anti-Ii reagent (Fig. 4, lanes 1, 3, and 5 ) indicated that Ii protein was produced in transfectants containing either wild-type or mutant Ii chain (Fig. 4A ) but that the Ii-CS form of Ii was generated only in the cells expressing the wild-type Ii chain (Fig. 4B ). Immunoprecipitates made with the anti-Ia monoclonal reagent (Fig. 4A, lanes 2, 4, and 6 ) contained coprecipitated Ii core protein when either the wild-type or the mutant Ii gene was present. As would then be expected, Ii-CS was coprecipitated with Ia only in cells expressing the GAG-bearing, wild-type Ii (Fig. 4B) . Two-dimensional electrophoretic analysis of immunoprecipitates (Fig. 4C) showed that the coprecipitating Mr 31,000 protein is truly Ii and corroborates the finding (Fig. 3 ) that both wild-type and mutant Ii proteins are equivalently transported through the Golgi apparatus. These two-dimensional gels also show that both the mutant and wild-type Ii molecules give rise to the Mr 25,000 Ii fragment (arrowheads), and further support the conclusion that these products are equivalently processed by the cell. The data indicate that the Ii Ala-201 mutation is specific for GAG attachment and that it does not appear to otherwise affect the processing of Ii or its assembly with Ia. Studies that employed partially purified xylosyltransferase and synthetic peptide acceptors (32) had suggested that the most-favored acceptor amino acid for xylose, the GAGinitiating monosaccharide, is serine followed in sequence by a glycine. The Ser-Gly acceptor site has been verified directly in two instances, for a heparin sulfate proteoglycan (33) and a dermatan sulfate proteoglycan (34) . At least one proteoglycan with a high GAG/protein ratio contains multiple contiguous attachment sites and has a repeating Gly-Ser sequence (40, 41) . Other proteoglycans with a low GAG/ protein ratio are paucisubstituted by GAG, including fibroblast chondroitin sulfate/dermatan sulfate proteoglycan of Mr 40,000 (42), a melanoma-associated chondroitin sulfate proteoglycan (43) , the heparin sulfate proteoglycan form of the transferrin receptor (44) , and the chondroitin sulfate proteoglycan form of Ii. Their core-protein structure, where it is known, shows a limited number of noncontiguous Ser-Gly sites that are potential acceptors for GAG. Comparison of neighboring amino acids around potential Ser-Gly addition sites has generated several hypotheses about the characteristics of GAG-acceptor sequences (40, 45) . Experimental evidence for the importance of various neighboring residues in the region of Ser-Gly acceptor sites has been obtained by analysis of in vitro xylosyltransferase activity (46) on synthetic peptide substrates (32, 45) . The neighboring sequence in the site we identified in murine Ii is consistent with the data identifying relevant residues in acceptor peptides.
DISCUSSION
The maturation of N-linked oligosaccharides of Ii (13, 47) and the addition of O-linked oligosaccharides (48) produces increasingly more acidic forms of Mr 31,000 Ii. The pattern of these acidic forms of Ii in the transfectants showed that, despite the failure of GAG addition, processing conferring charge heterogeneity on mutant Ii paralleled that found in the wild-type protein. This suggests that the failure of Ii Ala-201 to produce Ii-CS was not due to the inability of the mutant protein to be transported through the Golgi apparatus. In addition, analysis of the stable Ia' transfectants demonstrated that this mutation did not affect the ability of Ii to complex normally with Ia a and f3 chains. Thus, it was possible to introduce a single amino acid change and eliminate the GAG acceptor site in this core protein without severely disturbing its synthesis, other types of posttranslational processing, or assembly with other polypeptide chains.
Only a small percentage of total cellular Ii carries the GAG side-chain (11), but the ratio of Ii-CS to mature Ii may be somewhat higher, because much of the Ii synthesized seems to remain unprocessed in the endoplasmic reticulum. It is not clear whether a low proteoglycan/protein ratio is unusual for proteoglycans, because independent means of identifying both the core protein and the GAG-modified product are not available for most molecules of this type. It is interesting that a synthetic peptide, Ser-Ser-Gly-Leu-Gly, that corresponds to amino acids 200-204 of the murine Ii sequence and contains the GAG-addition site, is only marginally active as an acceptor peptide in the xylosyltransferase assay (M. Klinger, L. Roden, and S.E.C., unpublished data). These data could indicate that addition of xylose to Ii is somewhat inefficient and that the ratio of Is-CS to Ii is low partly for this reason. Alternatively, GAG addition may be the terminal event in the processing of all Ii molecules, and the small amount of Ii-CS present in cells may result from a short half-life for this form (11) . Detailed analysis of the transfectants containing the wild-type and mutant Ii genes may distinguish between these possibilities.
The structure and function of secreted proteoglycans, which form a large part of the extracellular matrix, have been extensively studied (31, 49, 50) , and these molecules have been shown to play an important role in determining the mechanical properties of tissues. Proteoglycans that localize in secretory vesicles may have a primary role in charge neutralization and efficient packaging of vesicular contents. The role of cell-membrane-associated proteoglycan is less clear. These surface molecules may function in cell-cell interactions and cellular adhesion (49) . Specific functions attributable to the core proteins themselves are generally not delineated, and the primary sequence of these proteins is just beginning to become available. Only two of the known core proteins, Ii and transferrin receptor, have been implicated in biological functions independent of GAG, and in these cases the exact role of the proteoglycan form is not yet clear.
In considering possible roles for Ii-CS, it is useful to review the biology of Ia molecules. These molecules are expressed on the cell surface of antigen-presenting cells such as macrophages and B lymphocytes. Soluble protein antigens taken up by these cells are internalized, denatured and/or degraded into peptides (processed), and displayed (presented) on the cell surface in the context of the Ia molecules. Recent studies (51) (52) (53) (54) indicate that a physical complex of Ia and peptide is formed. This complex of surface-expressed processed antigen and Ia is bound by the T-cell antigen receptor, leading to helper-T-lymphocyte activation and release of soluble lymphokines from the T cell. The observations that Ii-CS is associated with Ia during terminal biosynthesis (9) (10) (11) and at the cell surface (11) and that interference with the synthesis of Ii-CS is accompanied by loss of antigen-presenting function (16, 17) suggest some possible roles for Ii-CS in Ia biology. The Ii-CS molecule may enhance the binding between antigen-presenting cell and T cell, or it may affect Ia trafficking in ways that influence the association of Ia with processed antigen. In considering either model, it is important to recall that only a small fraction of Ia molecules may be associated with Ii-CS at any one time.
If Ii-CS enhances cellular adhesion between T cells and antigen-presenting cells, this enhancement could be relatively nonspecific, involving charge properties or lectin-type interactions. Alternatively, T-cell surface molecules that interact with Ia/li complexes (with or without antigen) may be specifically affected by the presence of the glycan on Ii. If Ii has a role in T-lymphocyte binding, this role could be either obligatory or enhancing, and these alternatives could be distinguished by using a transfection system to test the function of antigen-presenting cells in a quantitative fashion.
Another possibility is that Ii-CS may influence Ia function by directing recycled or newly synthesized Ia to a "specialized" cellular compartment where Ia/antigen complex formation may be influenced. The microenvironment within this putative compartment could either positively or negatively affect Ia binding to processed antigen. For example, recent evidence suggests that association of Ia with antigen fragments is not favored at low pH (54), the prevailing condition in endosomal and lysosomal compartments, and in addition, membrane-associated Ia is known to be very protease-resistant. Thus, Ia may recycle through an acidic and/or proteolytic compartment to clear protein fragments from internalized Ia and provide an opportunity for new associations to take place.
Recycling of Ia has not been well documented, however, although some Ia molecules have been localized to intracellular compartments (55, 56) . Quantitative assessment of Ia internalization has shown that, unlike transferrin-receptor recycling, internalization of Ia is slow and affects only 20% or less of surface Ia molecules, and return of the molecules 1362 Biochemistry: Miller et al. to the surface has not been verified (J.A.H. and S.E.C., unpublished data). Recycling of Ii itself has not been studied because surface-binding monoclonal reagents are not available. The idea that Ia/li-CS may be involved in recycling remains provocative because transferrin receptor, whose recycling properties are well established, shares with li the features of reverse membrane polarity and an alternative proteoglycan form. Transferrin receptor is known to recycle rapidly through a monensin-sensitive pathway (57) in which iron is unloaded in an intracellular acidic compartment. Though transferrin receptor has a proteoglycan form, the role of GAG in transferrin receptor recycling has not been investigated. It is possible that the proteoglycan forms of transferrin receptor or Ii traffic differently through the cells than their core-protein forms. It is unknown whether Ia internalization requires Ii or Ii-CS association, or whether a putative subsequent step, return of Ia (with or without new antigen fragments) to the surface of the antigen-presenting cell, might depend on its association with either Ii or extant li-CS or on its repassage with Ii through the Golgi. Even if such pathways are minor, they may be important to the function of antigen-presenting cells.
The concept that GAG is useful in antigen-presenting-cell function is consistent with the observation that xylosides, which inhibit proteoglycan synthesis (58) , diminish the capacity of spleen cells to serve as antigen-presenting cells (16, 17) . However, although the xyloside inhibition data show that proteoglycans play an important role in antigen processing and/or presentation, it is not clear that this finding is due to a specific effect on Ii-CS. The specificity of the mutation that we have described may provide a system to distinguish between the roles of Ii and li-CS in the immunobiology of Ia-antigen interactions and T-cell activation and/or in the intracellular transport or recycling of Ia molecules. In addition, this system may provide some insights into the biosynthesis and function of proteoglycan molecules and into specific roles played by GAG in various proteoglycan core proteins that can be engineered to prevent GAG attachment.
